Ferring Pharmaceuticals announced today three abstracts featuring ADSTILADRIN® (nadofaragene firadenovec-vncg) will be presented at the 2025 American Society of Clinical Oncologists Genitourinary ...
Arras Minerals Corp. (TSX-V:ARK)(OTCQB:ARRKF) ("Arras" or "Arras Minerals" or "the Company") is pleased to announce the ...
Dr. Montgomery Rice will be formally recognized at the Atlanta Business Chronicle's second annual Health Care Champion Awards ceremony on March 20, 2025.
2d
Max Estates Limited (MEL), has announced its unaudited Q3 & 9M FY25 financial results. * Real Estate Portfolio of 17 Mn. Sq. Ft. * Full-year pre-sales guidance surpassed in just 9 months, achieving ...
Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...
VANCOUVER, BC / ACCESS Newswire / February 11, 2025 / Arras Minerals Corp. (TSX-V:ARK)(OTCQB:ARRKF) ("Arras" or "Arras Minerals" or "the Company") is pleased to announce the results from the final fiv ...
CSL Behring's gene therapy Hemgenix four years post-infusion data continue to show sustained efficacy and safety in adults with haemophilia B: King of Prussia, Pennsylvania Monday ...
Welcome to AppLovin's earnings call for the fourth quarter and year ended December 31st, 2024. I'm David Hsiao, head o ...
Ladies and gentlemen, welcome to the Cognizant Technology Solutions’ Fourth Quarter 2024 Earnings Conference Call. All lines ...
While some believe the agency is in serious need of reform and oversight, others worry a vacuum of U.S. engagement could ...
Welcome to AppLovin's Earnings Call for the Fourth Quarter and Year ended December 31, 2024. I'm David Hsiao, Head of Investor Relations. Joining me today to discuss our results are Adam Foroughi, our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback